Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Core Insights - Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for brain diseases through novel mechanisms of action [3] - The company will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 11, 2026, at 4:00 p.m. ET [1] - A live webcast of the event will be available on the company's website, with a replay accessible for up to 30 days [2] Company Overview - Neumora's therapeutic pipeline includes seven neuroscience programs targeting underserved neuropsychiatric disorders and neurodegenerative diseases [3] - The company aims to redefine neuroscience drug development by utilizing an integrated suite of translational, clinical, and computational tools to enable precision medicine [3] - Neumora's mission is to improve treatment outcomes and quality of life for patients suffering from brain diseases [3]